0001950047-23-004316.txt : 20230929 0001950047-23-004316.hdr.sgml : 20230929 20230929165506 ACCESSION NUMBER: 0001950047-23-004316 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230929 DATE AS OF CHANGE: 20230929 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Adicet Bio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 231296411 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 19TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: resTORbio, Inc. DATE OF NAME CHANGE: 20171024 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 144 1 primary_doc.xml 144 0001340875 XXXXXXXX LIVE 0001720580 ADICET BIO, INC. 001-38359 200 Berkeley Street 19th Floor Boston MA 02116 (650) 503-9095 CHEN SCHOR Officer Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

5500 7480.55 43066158 09/29/2023 NASDAQ Common 08/04/2022 Performance Stock Units Issuer N 5500 08/04/2022 Cash Y 09/29/2023 /s/ Chen Schor